【持续性肾脏替代治疗crrt英文精品课件】cbpnephrology – diseases of the kidneys!(102p)_第1页
【持续性肾脏替代治疗crrt英文精品课件】cbpnephrology – diseases of the kidneys!(102p)_第2页
【持续性肾脏替代治疗crrt英文精品课件】cbpnephrology – diseases of the kidneys!(102p)_第3页
【持续性肾脏替代治疗crrt英文精品课件】cbpnephrology – diseases of the kidneys!(102p)_第4页
【持续性肾脏替代治疗crrt英文精品课件】cbpnephrology – diseases of the kidneys!(102p)_第5页
已阅读5页,还剩97页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

CBP Nephrology Diseasesofthekidneys CBP Nephrology A48 year oldman otherwisehealthy presentswithsevereunspecificabdominalpainandvomitingof2daysduration Heisastablebipolarpersonalitydisorderonlithium anXsmoker hashistoryofalcoholuse CBP Nephrology Onphysicalexamination restless dehydratedHR130andBP90 60 Supine RR28 T37 4 Chestandheartexamsareunremarkable Abd examrevealedmild moderateepigastricabdominaltendernesswithoutperitonealsigns Restoftheexamisunremarkable Lab WBCis16 500 andtheHCTis49 Cr188 67baseline BUN12 3 K5 5andtherestofelectrolytevaluesarenormal CBP Nephrology IntubatedonadmissionduetoalteredLOCandinabilitytoprotecthisairwayaswellasimpendinghypoxemicrespiratoryfailure remainsonmultiplevasoactiveagents andisinoliguric to anuricrenalfailureAdmittedtoICUandadequatelyresuscitatedPatientremainsanuricdespitetheadequatefluidresuscitation Question1 AnyroleforincreasingdosesofLasixinananuricpatient Anyharm Anybenefit Eric DiureticsinAKI DiureticsinAKI Threepartquestion ElectrolytemanagementFluidmanagementConversionofoligurictonon oliguricRF Electrolytes Fluid PaucityofdataansweringthesespecificquestionsRemainsclinicaldecisionandtherapeuticoption Differentiatefluidmanagementfromurineoutput Conversionofoligurictonon oliguricRF RavindraLMetal Diuretics Mortality andNonrecoveryofRenalFunctioninAcuteRenalFailure JAMA 2002 288 20 2547 2553 Confounders Diureticuseatthetimeofconsultationwassignificantlyassociatedwitholderage presumednephrotoxic ratherthanischemicormultifactorial ARForigin alowerBUNlevel acuterespiratoryfailure andahistoryofcongestiveheartfailure CausevsCorrelate Afteradjustingforcovariatesassociatedwiththeriskofdeath diureticusewassignificantlyassociatedwithin hospitalmortalityannon recoveryofrenalfunction evenafteradjustmentfornonrandomtreatmentassignmentusingpropensityscores DiureticsinAKI Threepartquestion Electrolytemanagement Fluidmanagement Conversionofoligurictonon oliguricRF Question2 DefineAcuteKidneyInjury Eric DefinitionsofAKI Thedilemma Morethan35definitionsofAKIcurrentlyexistintheliterature AKIvsAcute ChronicRF CritCareMed2010 38 261 275 RIFLEvsAKIN Bagshawetal AcomparisonoftheRIFLEandAKINcriteriaforacutekidneyinjuryincriticallyillpatients NephrolDialTransplant 2008 23 1569 1574 BottomLine BoththeRIFLEandAKINcriteriaweredevelopedtofacilitateclinicalinvestigationandcomparisonacrossstudypopulations Todate mostinterventionalstudies e g NAC NaHCO3 etc topreventormitigateAKIhavenotusedthesedefinitions Question3 WhatistheincidenceofAKIintheICUandhowdoesitaffectpatientoutcomes yahya IncidenceofAKIintheICU AKIoccursin 7 ofallhospitalizedpatients whereasitoccursin36 67 ofcriticallyillpatients Onaverage 5 ofICUpatientswithAKIrequirerenalreplacementtherapy DennenP DouglasIS AndersonR Acutekidneyinjuryintheintensivecareunit anupdateandprimerfortheintensivist CritCareMed 2010Jan 38 1 261 75 AKIandmortality Inmoststudies mortalityratesriseproportionallywithseverityofAKI EvensmallincreasesinserumcreatininehavebeenassociatedwithincreasingmortalityinvariousICUpopulationsdespiteadjustingforseverityofillnessandcomorbidities InpatientswithAKIrequiringRRT mortalityratesreach50 to70 DennenP DouglasIS AndersonR Acutekidneyinjuryintheintensivecareunit anupdateandprimerfortheintensivist CritCareMed 2010Jan 38 1 261 75 AKIandotheroutcomes AKIisalsoassociatedwith IncreasedlengthofstayIncreasedincidenceofCKDandend stagekidneydiseaseIncreasedcostForexample anincreaseinSCrof0 5mg dl 38mmol L wasassociatedwitha 6 5 foldincreaseintheoddsofdeath3 5dayincreaseinLOSnearly 7500inexcesshospitalcosts DennenP DouglasIS AndersonR Acutekidneyinjuryintheintensivecareunit anupdateandprimerfortheintensivist CritCareMed 2010Jan 38 1 261 75 ChertowGM BurdickE HonourM BonventreJV BatesDW Acutekidneyinjury mortality lengthofstay andcostsinhospitalizedpatients JAmSocNephrol 2005Nov 16 11 3365 70 Question4 Whatarethemethodsfordetectingacutekidneyinjury yahya TraditionalmethodsfordetectingAKI Currentlyavailablemeasuresdonotdetectactualkidneyinjurythewaytroponindetectsmyocardialinjury CreatinineUreaUrineoutputRathertheyaremarkersofabnormalrenalfunction thatcanbeusedtopresumekidneyinuryhasoccurred BagshawSM BellomoR Earlydiagnosisofacutekidneyinjury CurrOpinCritCare 2007Dec 13 6 638 44 Serumcreatinine UsedtoestimateGFRProsProducedatarelativelyconstantrateFreelyfilteredbyglomerulusNotreabsorbedormetabolizedbythekidney BagshawSM BellomoR Earlydiagnosisofacutekidneyinjury CurrOpinCritCare 2007Dec 13 6 638 44 Serumcreatinine UsedtoestimateGFRCons10 40 issecretedbythetubulesRelativelyinsensitive mayneeda50 reductioninfunctionbeforeadetectableriseinSCrisseen Creatinineproductionvariesbasedonage sex musclemass dietCertaindiseasestatescanincreaseproduction rhabdo Certaindrugscandecreasesecretion cimetidine trimethoprim Certainfactorsmayaffectassay ketoacidosis cefoxitin flucytosine Doesnotreflectreal timechangesinGFR BagshawSM BellomoR Earlydiagnosisofacutekidneyinjury CurrOpinCritCare 2007Dec 13 6 638 44 Urea RateofproductionisnotconstantIncreaseswithproteinintakeIncreasesincriticalillness burns sepsis trauma GIBleedSteroids40 50 ofureaisreabsorbedbythekidney evenmorewhendry BagshawSM BellomoR Earlydiagnosisofacutekidneyinjury CurrOpinCritCare 2007Dec 13 6 638 44 Urineoutput ProsAdynamicgaugeofkidneyfunction MaybeabarometerforchangeinkidneyperfusionConsPoorsensitivityandspecificityCanhavesevereAKIwithnormalorincreasedurineoutput BagshawSM BellomoR Earlydiagnosisofacutekidneyinjury CurrOpinCritCare 2007Dec 13 6 638 44 Summaryofnovelmarkers BagshawSM BellomoR Earlydiagnosisofacutekidneyinjury CurrOpinCritCare13 638 644 CBP Nephrology Patientcontinuestohaveincreasingventilationsupportrequirmentsandisnowon 85FiO2 HisK isnow5 6 HeisgivenroutinehyperK therapy HehasbeenstartedonvasopressorsbecauseofdecliningMAP Question6 WhenshouldRRTbestarted Indicationandtiming Brian Historicalaspects UseofHDinARFstartedintheyearsimmediatelyfollowingWWII 1947 1950 Initialindications advancedsymptomsofrenalfailure clinicaluremia severehyperkalemia pulmonaryedemaReductioninmortalitycouldnotbedemonstrated withhighcomplicationratesTeschanetalreportedimprovedsurvivalwith prophylacticdialysis in1960 Indisputable indications VolumeoverloadHyperkalemiaMetabolicacidosisUremicsignsorsymptomsRefractorytomedicalmanagementNospecificobjectivecriteria OtherIndications Progressiveazotemiaintheabsenceofuremia noconsensus Otherelectrolytedisturbances Na Mg PO4 Uricacid TimingofinitiationofRRT CompetingrisksRiskofdelayintherapyPotentialharmoftherapy includingcomplicationsoftherapyandthepotentialthatdialysismayprolongthecourseofARF Teschanetal Prophylactichemodialysisinthetreatmentofacuterenalfailure AnnIntMed1960 PaulTeschanofUSArmyMedicalCorpsaftertheKoreanWarintroducedtheconceptof prophylacticdialysis appliedbeforeoverturemicsymptomsappearedN 15 uncontrolledtrial initiationofdialysisbeforeserumUreaNitrogenreached100mg dlTwincoilcellulosicdialyzersatBF75 250ml mintomaintainBUNlessthan75mg dlAllcausemortality33 mortalityduetohemorrhageorsepsis20 Nocontrolgroup However investigatorsreportedthattheresultrepresented dramatic increaseinsurvivalcftheirpastexperienceinptinwhomdialysiswasnotinitiateduntil conventional indicationswerepresent Earlystudies Boumanetal CCM2002 2centerRCT n 106 ICUptsonMVwithvasopressordependentcirculationandoliguricARFARF CrCl40mmol l pulmonaryedemawithPaO2 FiO2 150despitePEEP10Manyissues Jiang etal 2005 RCT n 37 inseverepancreatitisWITHOUTdocumentedevidenceofARFEarly CVVHwithin48hoursonsetofabdopainLate within96hoursImprovedhemodynamicsand14dsurvival Gettingsetal ICM1999 Retrospectivenonrandomizedcohortstudy n 100 Traumapatients Timing definedbyBUNlevelEarly RRTstartedatameanBUN15mmol lLate atBUN34mmol LSurvival 39 Early 20 Late Piccinietal ICM2006 Retrospectivestudy n 80 PatientswithsepticshockandoliguricAKIHistoricalcontrolEarly 35mmol lorCr 600Improvedhemodynamics gasexchange 28dsurvival Elahietal 2004 Retrospectivecohortstudy n 80 CardiacsurgerypatientsEarly CVVHwhenUO30mmol l Cr 250 orK 6regardlessofUOSurvival44 early 22 late p 0 05 Demirkilicetal 2004 Retrospectivestudy n 61 ARFfollowingcardiacsurgeryHistoricalcontrolEarly CVVHDFifUO444Hospitalmortality23 5 Early55 latep 0 02 Summary TrendtowardsbetteroutcomewithearliertimingofRRTMethodologypoorNonuniformdefinitionoftimingHeterogeneityofpopulationHeterogeneityofRRT Summary NonuniformandarbitrarydefinitionofARFpreventsdirectcomparisonoftrialsButhowaboutusingRIFLEcriteriaandAKINdefinition Shiaoetal 2009 MulticenterprospectiveobservationalstudyN 98whounderwentRRTaccordingtolocalindicationsforpost majorabdosurgeryAKIEarly sRIFLE 0orRiskLate sRIFLE IorF RIFLE AKIN Results N 98Early 51 0 22 R 29 Late 47 I 27 F 20 ICUmortality Early41 2 Late68 1 Hospitalmortality Early43 1 Late74 5 p 0 002 RRTwean offrate 21 vs41 p 0 050 Conclusions Limitations LatedialysisdefinedbysRIFLE IorsRIFLE FisanindependentpredictorforinhospitalmortalitySupportearlierinitiationofRRTSmallNOnlyGFRcriterionofRIFLEused sRIFLE Question7 DefinedifferentmodesofRRT Brian RRTmodalities Diffusion Convection SCUF CVVH CVVHD CVVHDF IHD Bloodflow200 300ml minDialysateflow500 800ml minSoluteremovalbydiffusion fluidremovalbyultrafiltrationSoluteclearancedependentonbloodflowAdvantages rapidsoluteandfluidremoval rapidelectrolytecorrection certaintoxinremoval noneedforanticoagulationDisadvantages systemichypotension RenalReplacementTherapy AllformsofRRTrelyontheprincipleofallowingwaterandsolutetransportthroughasemipermeablemembraneanddiscardingwasteproductsFluidremoval ultrafiltrationSolutetransport diffusion convection orboth Question8 IHDvsCRRT Brian Dialysismodality 1999NKFsurveyrevealedIHDaspreferredformofRRT 75 whileCRRT PDwaslessthan10 MorerecentsurveyrevealedIHDaspreferredbynephrologists intensivistsin57 whileCRRTwaspreferredin37 inUSInternationally BESTKidneystudy JAMA2005 revealedCRRTastheinitialmodalityofchoiceforRRTinICUusedin80 followedbyIHD 17 So isCRRTbetter PreferenceofCRRT Putativeadvantages ImprovedhemodynamicstabilityMoreeffectivecontrolofacid baseandelectrolytestatusImprovedremovalofuremictoxinsRemovalofinflammatorymediators Disadvantages Needforanticoagulation2 3xmoreexpensivethanIHD Evidence Two2002metaanalysesofearliertrialscomparingsurvivalinICUAKIassignedtoIHDorCRRTandadjustedforseverityofillnessdidnotsupportCRRTSeveralobservationalandprospectiveRCTscomparingIHDvsCRRTfailedtoconfirmexpectedsurvivaladvantageofCRRTLimitations dosedifference highcrossoverrate randomizationfailure nonstandardizationofprotocol CochraneReview2008 Intermittentvs continuousRRTforARFinadults Objectives TocompareCRRTwithIRRTtoestablishifanyofthesetechniquesissuperiortoeachotherinpatientswithAF Methods Typesofstudies RCTsInterventionsIRRTdefinedasanyformofRRT HD HF HDF UF prescribedforperiodof 24hwithinany24hperiodCRRTdefinedasanyRRTintendedtorunonacontinuousbasisuntilrecoveryofrenalfunctionoccurred Methods OutcomemeasuresMortality priortoICU hospitalDC timetoICU hospitaldeath DCRecoveryofrenalfunctionCardiovascularstabilityComplicationsoftherapy bleeding sepsis Results Mortality In hospitalmortality nodifference 7studies N 1245 RR1 01 0 92 1 12 noevidenceofsignificantheterogeneityICUmortality nodifference 5studies N 515 RR1 03 0 90 1 26 Timetohospitaldeathordischarge nodifference 1study N 25 TimetoICUdischargeordeath notassessed Results RecoveryofRF Survivingptnotrequiringdialysis Nodifference 3 N 161 RR0 99 0 92 1 07 noevidenceofsig heterogeneitysCroreGFRathospitaldischarge nodifference 1 N 129 RR1 13 0 94 1 36 Results Cardiovascularstability Hemodynamicinstability nodifference 2 N 205 RR0 48 0 2 2 28 Onestudydidnotspecifydefinition whiletheotherdefineditasavaeragevariabilityb wmaxadmindailyMAP NoheterogeneityHypotension Nodifference 3 N 514 RR0 92 0 72 1 16 VariabledefinitionofhypotensionMAPatendofstudy CRRTsignificantlyhigher 2 N 112 meandif5 35 1 41 9 29 SystolicBP Nodifference 1 N 30 Escalationofpressorrx NodifferencewhenanalysedbyrandomeffectsmodelDoseofinotropicdrugs nodifference Results ComplicationsofRRT Bleeding nodifference 5 N 638 Clottingofdialysisfilter CRRTsignificantlymorelikelytoclotfilter 3 N 149 RR8 5 1 14 63 33 Arrhythmia nodifference 2 N 439 RRTmodalityswitchduetocomplications nodifference 4 N 920 Conclusions CRRToffersnosurvivaladvantagecfIRRTinARFPtsurvivingARFwhoaremanagedwithCRRThassimilarrecoveryofRFasthosetreatedwithIRRTCRRTisassociatedwithsighigherMAPCRRTisassociatedwithsigincreasedfilterclotting Limitations EachRCTsarenotlargeenoughtoprovideanaccurateevaluationofthedifferenceinoutcomeConsiderablevariationsindefinitionofARFandhypotension heterogeneityindialysisx dose membrane andptcharacteristics WhatkindofanticoagulationshouldbeusedwithCRRT UBCAHDNephrologyCBPSamuelKohenNovember18 2010 Introduction CRRTisusedinhemodynamicallyunstablepatientswithrenalfailure ThemostcommonproblemwithCRRTiscircuitclotting Anticoagulationdecreasesthis HeparinandCitratearethetwomostcommonCRRTanticoagulants Untilrecently itwasnotclearwhichwasbetter Heparin IVinfusionadministeredintotheinflowlimboftheextracorporealcircuit IVBolusof500 2000Utheninfusionof300 500U htitratedtoagoalPTT1 5 2xnormal Stopheparinforbleedingorthrombocytopenia Citrate Citrateinhibitsclottingbychelatingcalcium IVcalciumisinfusedpost circuittomaintainnormalserumCalevels Citrateisbasicsotheotherdialysatebuffers bicarbonateorlactate mustbereducedItishepaticallymetabolizedbythepatient Citrateversusheparinforanticoagulationincontinuousvenovenoushemofiltration aprospectiverandomizedstudy Mehranetal IntensiveCareMed 2004 30 260 265 Mehranetal Prospectivetrialrandomizing20patientsreceivingCVVHFtoheparinorcitratebyhemofilter 49hemofiltersused 23heparinand26citrate Patientsrequiringmorethanonehemofilterwerecrossedover Patientswithliverdysfunctionordeemedathighriskofbleedingwereexcluded Mehranetal ThereisnodifferenceinCRRTfunction ureaandcreatinineclearance Themediancircuitlifetimewaslongerwithcitratethanheparin 70vs40hours mostlyduetoclotting 74vs46 Citrateanticoagulationisassociatedlessbleeding Fewersignificantbleedingepisodes 1UGIBvs0 FewerPRBCtransfusions 1U dvs0 2U d CitrateismoreoftenassociatedwithmetabolicderangementsMetabolicalkalosisandhypocalcemia Regionalcitrateversussystemicheparinizationforcontinuousrenalreplacementincriticallyillpatients Demetriosetal Kidneyinternational Vol67 2005 P2361 2367 Demetriosetal 30criticallyilladultpatientswithacuterenalfailureonCRRTwererandomizedtoeitherheparin 16 orcitrate 14 2patientscrossedovertreatmentgroups 79hemofilterswereused Heparin 43 Citrate 36 Demetriosetal Nosignificantdifferenceinsurvivaltohospitaldischarge Citrate14 Heparin29 p 0 69 Filtersusingcitratefunctionedmuchlongerthanthosewithheparin 124 5vs38 3hours Conclusions Citrateisbetter Nodifferenceincreatinineclearanceor60daymortality Citratetreatedcircuitsclotlessfrequentlyandlastlonger Citrateanticoagulationisassociatedwithfewerbleedingepisodes Metabolicalkalosisandhypocalcemiaarethemostcommoncomplicationsofcitrate treatedcircuitsbutareeasilydetectedandusuallyharmless WhatarewedoingatVGH Primethecircuitwith5000Uhep

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论